Not cancer · Austria
Alzheimer disease
How is it diagnosed today? There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.5 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Symptom medicines (e.g. donepezil) plus support. NHS
5 medicines are approved for this disease in Austria:
- Donanemab (Kisunla) – approved in 2025
- Lecanemab (Leqembi) – approved in 2025
- Memantine (Memantine Mylan, Memantine ratiopharm, memantine hydrochloride) – approved in 2013
- Memantine hydrochloride (Memantine Merz) – approved in 2012
- Rivastigmine (Rivastigmine, Exelon, Exelon Patch) – approved in 2009
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (7)
- Benzgalantamine (Zunveyl) – approved for it in the US
- Brexpiprazole (Rexulti) – approved for it in the US
- Dextromethorphan and bupropion (Auvelity) – approved for it in the US
- Donepezil (Aricept, Donepezil Sandoz) – approved for it in the US, Switzerland, and France
- Galantamine (Galantamine, Reminyl PR, Galantamine Biogaran Lp) – approved for it in the US, Switzerland, and France
- Memantine and donepezil (Namzaric) – approved for it in the US
- Risperidone (Risperdal, Risperidone Eg) – approved for it in France
Being tested in people
5 open trials in Austria, 618 worldwide. See the trials
- ACP-204 (Phase 3)
- AR1001 (Phase 3)
- Atomoxetine (Phase 3)
- buntanetap/posiphen (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 4 were in animals and 1 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Mistletoe extract (only single reports in people)
- Hyperthermia (animal studies only)
- Ivermectin (animal studies only)
- Dichloroacetate (DCA) (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters. You can also show trials abroad.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- End-to-end deep learning for identifying Alzheimer's disease signatures in spectral fluorescence imaging of normal-appearing brain regions in 5xFAD mice.J Med Imaging (Bellingham) · 2026-11-06
- Neurotherapeutic potential of photobiomodulation in a 3D Model of Alzheimer's disease induced by oxidative stress.In Vitro Model · 2026-05-04
- Smoking and dementia risk: an updated systematic review and meta-analysis of 61 prospective cohort studies and implications for tobacco control.EClinicalMedicine · 2026-11-07
- Plasma biomarker signatures in patients with rapidly progressive dementia.Alzheimers Dement (Amst) · 2026-11-13
- ReviewElevated Phosphorylated Tau and Amyloid-Beta 42 in Sleep Apnoea: Evidence From a Systematic Review and Meta-Analysis.Biomed Res Int · 2026-01-01
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Alzheimer Austria
Self-help organisation for 35+ years: free confidential counselling by appointment (alzheimeraustria@aon.at), young-onset group, peer counselling, partner and adult-children groups, Alzheimer Cafe, carer course.
- Demenz Selbsthilfe Austria
Federation and umbrella organisation of dementia self-help groups in Austria (founded 2021); Alzheimer Europe full member.
- Demenzstrategie „Gut leben mit Demenz“
Public portal of Austria's national dementia strategy with material for people with dementia and relatives and links to regional services.
- Fonds Demenzhilfe Österreich (Volkshilfe Demenzhilfe)
Volkshilfe initiative giving financial aid to people with dementia at risk of poverty; information on counselling, self-help groups and care services.
- MAS Alzheimerhilfe
Dementia service points (information and practical help for people with dementia and relatives), guided self-help groups, Alzheimer holiday for couples, carer tips.
Phone: +43 6132 214 10
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (9)
- Alzheimer's Association
Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.
- Alzheimer's Drug Discovery Foundation
Funds the early work on new Alzheimer's medicines, in universities and companies.
Phone: 212.901.8000
- BrightFocus Foundation
US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.
- Dementia Alliance International (DAI)
Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.
- Alzheimer Europe
Umbrella of national Alzheimer associations in 39 countries, with a member directory.
- Alzheimer's Disease International (ADI)
Global federation of dementia associations in 100+ countries: member associations list, find local support, dementia information, World Alzheimer Report.
- European Federation of Neurological Associations (EFNA)
Umbrella of 21 pan-European neurology patient groups; map of European neurology patient organisations.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.